Literature DB >> 21426464

Ethnicity and lupus nephritis: an Australian single centre study.

C Ong1, K Nicholls, G Becker.   

Abstract

BACKGROUND: The clinical impression of Australian physicians is that systemic lupus erythematosus (SLE) is more prevalent and more severe in Asian patients than in their Caucasian counterparts. The presence and severity of lupus nephritis is a major determinant of prognosis in SLE, and largely determines disease impact. AIM: To analyse the relationships between ethnicity and the prevalence and severity of lupus nephritis (LN) in patients attending a tertiary referral centre (The Royal Melbourne Hospital (RMH)).
METHODS: The ethnicity of all known patients with biopsy-proven LN was determined according to three definitions of ethnicity - ancestry, country of origin and primary language spoken. The prevalence of Asian ethnicity in the LN cohort was analysed across severity class, and was compared with the prevalences of Asian ethnicity in the general population within the hospital's geographic area, and with that in the relevant RMH cohorts of inpatients and outpatients, over the same time period.
RESULTS: Within this single tertiary centre, Asian patients were disproportionately represented in both the systemic lupus erythematosus (SLE) and the LN patient groups, although the distribution of histological severity of LN was not significantly different from Caucasian patients.
CONCLUSION: This study supports the common clinical impression that SLE is more common and more severe in the Asian-Australian population. Asian patients with SLE were more commonly diagnosed with LN. However, the spectrum of histological severity of LN was similar in Asian and Caucasian patients.
© 2011 The Authors. Internal Medicine Journal © 2011 Royal Australasian College of Physicians.

Entities:  

Mesh:

Year:  2011        PMID: 21426464     DOI: 10.1111/j.1445-5994.2009.02159.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  9 in total

Review 1.  Lupus Nephritis: A Different Disease in European Patients?

Authors:  Vladimir Tesar; Zdenka Hruskova
Journal:  Kidney Dis (Basel)       Date:  2015-08-28

Review 2.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

3.  Renal biopsy pathology in a cohort of patients from southwest Sydney with clinically diagnosed systemic lupus erythematosus.

Authors:  Jim Lc Yong; Murray C Killingsworth; Ken Lai
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-02-13

Review 4.  Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies.

Authors:  Ziqian Wang; Yanhong Wang; Rongrong Zhu; Xinping Tian; Dong Xu; Qian Wang; Chanyuan Wu; Shangzhu Zhang; Jiuliang Zhao; Yan Zhao; Mengtao Li; Xiaofeng Zeng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

5.  A clinicopathological study on lupus nephritis; experience of 34 cases from Bangladesh.

Authors:  Muhammad Nazmul Baqui; Shabnam Akhter; Enamul Kabir; Mohammad Shamiul Islam
Journal:  J Nephropharmacol       Date:  2015-07-22

6.  Lupus nephritis in Bangladesh: unfolding the story.

Authors:  Muhammed Mubarak
Journal:  J Nephropharmacol       Date:  2016-01-02

7.  Clinical & immunological characteristics in systemic lupus erythematosus patients.

Authors:  Maryam Rastin; Mahmoud Mahmoudi; Maryam Sahebari; Nafiseh Tabasi
Journal:  Indian J Med Res       Date:  2017-08       Impact factor: 2.375

8.  Characteristics and Histological Types of Lupus Nephritis in a Jordanian Tertiary Medical Center.

Authors:  Randa I Farah; Ebtesam Dannoun; Nisreen Abu Shahin; Saif Aldeen AlRyalat
Journal:  Biomed Res Int       Date:  2019-03-25       Impact factor: 3.411

9.  Protocol and establishment of a Queensland renal biopsy registry in Australia.

Authors:  Joseph Patrick Burke; Manaf Aljishi; Leo Francis; Wendy Hoy; Dakshinamurthy Divi; Roy Cherian; Jeremy Frazier; Glenda Gobe; Pedro Gois; Sridevi Govindarajulu; Sonny Huynh; Shilpanjali Jesudason; George John; Krishan Madhan; Andrew Mallett; Valli Manickam; Clyson Mutatiri; Shu-Kay Ng; Zaw Thet; Peter Trnka; Sree Krishna Venuthurupalli; Dwarakanathan Ranganathan
Journal:  BMC Nephrol       Date:  2020-08-01       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.